Health Canada drug identification number

DIN 02522365 — NEXVIAZYME 100 MG

NEXVIAZYME is a powder for solution of Avalglucosidase alfa marketed by SANOFI-AVENTIS CANADA INC. The full Avalglucosidase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02522365
Brand name
NEXVIAZYME
Active ingredient
Avalglucosidase alfa
Strength
100 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
SANOFI-AVENTIS CANADA INC
Health Canada status
MARKETED
Drug class
Enzyme replacement therapy (recombinant human acid alpha-glucosidase)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.